Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I.
2010-12-17
Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II
2010-12-17
Registered
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II
2010-12-17
Registered
NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III.
2010-12-17
Registered
Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors.
2010-12-17
Registered
1E10 anti-idiotype vaccine, metastatic colon, phase II.
2010-12-03
Registered
99mTc-marked 14F7 MaB in metastatic breast, phase II
2008-12-27
Registered
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT
20/10/2021
Registered
NeuroEPO in mild-moderate Alzheimer's disease
20/09/2022
Registered
CIMAvaxEGF in Non Small Cell Lung Cancer. Exploratory Study of Biomarkers
20/06/2024
Registered
NeuroEPO-Ataxia-Adults-Phase III
19/11/2020
Registered outdated
Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors.
18/06/2024
Registered
CIMAvax-EGF®-post-COVID19 convalescent with respiratory disorders-adults-Phase II (CORVAXCIM)
18/06/2021
Registered outdated
ior®EPOCIM in post-COVID-19 convalescent patients with cardiovascular, renal and/or respiratory disorders
18/06/2021
Registered outdated
Biomodulina T- CIMAvax-EGF-Advanced Non-Small Cell Lung Cancer-Adults
18/03/2021
Registered outdated
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial
17/10/2018
Registered
Study of the mechanism of action of Nimotuzumab in patients with head and neck tumors
17/02/2017
Registered
Her1 vaccine in metastatic colon and prostate cancer
16/08/2023
Registered
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients
15/12/2015
Registered
Vaxira as adjuvant treatment for non-small cell lung cancer
15/12/2015
Registered outdated
« first
‹ previous
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform